title: Costs of running a universal adolescent hepatitis B vaccination programme.
abstract: In the first UK study to examine feasibility and acceptability of universal adolescent hepatitis B vaccination, the costs associated with the administration and uptake (80.2 and 89.3% for three doses and at least two doses, respectively), of a three-dose regimen in pupils in Glasgow schools (2001/2002) were measured. These data were used to estimate the economic outlay for the delivery of a routine, ongoing three-dose and two-dose hepatitis B vaccine programme in schools. Vaccine, accounting for almost 70% of the overall costs, was the largest cost item for both the pilot and routine programmes, using either regimen. However, the ongoing, two-dose regimen was the cheapest option in this analysis, irrespective of vaccine price. Cost data from this study may be useful for other countries wishing to implement a similar programme.
authors.affiliation: Health Protection Scotland, Clifton House, Clifton Place, Glasgow G3 7LN, UK. lesley.Wallace@hps.scot.nhs.uk
authors.forename: L A
authors.initials: LA
authors.lastname: Wallace
authors.forename: D
authors.initials: D
authors.lastname: Young
authors.forename: A
authors.initials: A
authors.lastname: Brown
authors.forename: J C
authors.initials: JC
authors.lastname: Cameron
authors.forename: S
authors.initials: S
authors.lastname: Ahmed
authors.forename: R
authors.initials: R
authors.lastname: Duff
authors.forename: W F
authors.initials: WF
authors.lastname: Carman
authors.forename: N R E
authors.initials: NR
authors.lastname: Kitchin
authors.forename: J S
authors.initials: JS
authors.lastname: Nguyen-Van-Tam
authors.forename: D J
authors.initials: DJ
authors.lastname: Goldberg
mesh_terms: D000293:Adolescent; D016497:Adolescent Health Services / Q000191:economics* / Q000706:statistics & numerical data; D003153:Community Health Services / Q000191:economics / Q000706:statistics & numerical data; D003362:Cost-Benefit Analysis; D005240:Feasibility Studies; D006291:Health Policy; D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage* / Q000191:economics*; D006801:Humans; D017589:Immunization Programs / Q000191:economics* / Q000458:organization & administration / Q000706:statistics & numerical data; D007115:Immunization Schedule; D015397:Program Evaluation; D012572:School Health Services / Q000191:economics / Q000458:organization & administration / Q000706:statistics & numerical data
chemical_list: D017325:Hepatitis B Vaccines